We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Labor shortages and staff burnout among nurses are reasons to be wary of AMN Healthcare Services (AMN - Free Report) stock despite the company’s favorable long-term prospects.
Correlating with this cautious scenario, AMN’s stock currently carries a Zacks Rank #5 (Strong Sell) and lands the Bear of the Day.
Image Source: Zacks Investment Research
Declining Nurse and Allied Solutions Segment Sales
Providing total talent solutions and staffing networks for healthcare organizations, AMN’s Nurse and Allied Solutions segment revenue fell -38% last quarter to $538 million with the company stating its travel nurse sales fell -40% specifically.
AMN was still able to beat Q4 top and bottom line expectations in February but this is concerning considering the Nurse and Allied Solutions segment makes up more than half of its total revenue.
Image Source: Zacks Investment Research
Furthermore, the impact of challenging work conditions and high turnover particularly among "Nurse Leaders" is lingering with AMN forecasting its Nurse and Allied Solutions segment revenue to be down 36-38% for the first quarter. AMN projects its consolidated revenue for Q1 to be 26-28% lower with Zacks estimates of $814.46 million representing a -27% decline.
Image Source: Zacks Investment Research
Bottom Line Effect
With the proponents of nurse staffing making up such a large chunk of AMN’s core business, the company’s bottom line is expected to be impacted as well. Notably, earnings estimate revisions have declined -20% for fiscal 2024 over the last 30 days from projections of $4.93 per share to $3.97 a share.
Image Source: Zacks Investment Research
Plus, FY25 EPS estimates have fallen -14% in the last month which is starting to put a dent in the hopes of a sharp rebound in AMN’s bottom line next year.
Image Source: Zacks Investment Research
Takeaway
AMN’s stock is already down -20% year to date and a rebound may not come until its Nurse and Allied Solutions segment sales begin to stabilize. This will need to be monitored by investors going forward and for now, AMN’s stock is one to avoid.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Bear of the Day: AMN Healthcare Services (AMN)
Labor shortages and staff burnout among nurses are reasons to be wary of AMN Healthcare Services (AMN - Free Report) stock despite the company’s favorable long-term prospects.
Correlating with this cautious scenario, AMN’s stock currently carries a Zacks Rank #5 (Strong Sell) and lands the Bear of the Day.
Image Source: Zacks Investment Research
Declining Nurse and Allied Solutions Segment Sales
Providing total talent solutions and staffing networks for healthcare organizations, AMN’s Nurse and Allied Solutions segment revenue fell -38% last quarter to $538 million with the company stating its travel nurse sales fell -40% specifically.
AMN was still able to beat Q4 top and bottom line expectations in February but this is concerning considering the Nurse and Allied Solutions segment makes up more than half of its total revenue.
Image Source: Zacks Investment Research
Furthermore, the impact of challenging work conditions and high turnover particularly among "Nurse Leaders" is lingering with AMN forecasting its Nurse and Allied Solutions segment revenue to be down 36-38% for the first quarter. AMN projects its consolidated revenue for Q1 to be 26-28% lower with Zacks estimates of $814.46 million representing a -27% decline.
Image Source: Zacks Investment Research
Bottom Line Effect
With the proponents of nurse staffing making up such a large chunk of AMN’s core business, the company’s bottom line is expected to be impacted as well. Notably, earnings estimate revisions have declined -20% for fiscal 2024 over the last 30 days from projections of $4.93 per share to $3.97 a share.
Image Source: Zacks Investment Research
Plus, FY25 EPS estimates have fallen -14% in the last month which is starting to put a dent in the hopes of a sharp rebound in AMN’s bottom line next year.
Image Source: Zacks Investment Research
Takeaway
AMN’s stock is already down -20% year to date and a rebound may not come until its Nurse and Allied Solutions segment sales begin to stabilize. This will need to be monitored by investors going forward and for now, AMN’s stock is one to avoid.